Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal L24 domain containing 1 pseudogene 11 (RSL24D1P11) is an annotated human pseudogene, meaning it is a segment of DNA with strong similarity to a protein-coding gene (RSL24D1) but is generally considered nonfunctional for protein production[9][7][3]. RSL24D1P11 belongs to a family of ribosomal protein pseudogenes derived from ribosomal protein L24 domain-containing genes. There is no evidence it produces a protein or serves as a conventional therapeutic target. While some pseudogenes can regulate parental gene expression or participate in RNA-mediated regulation[6][8], no literature specifically describes a biological or disease-related function for RSL24D1P11. This pseudogene is not targeted by drugs, is not a diagnostic or predictive biomarker, nor is it implicated in disease by current knowledge[9][7][3].
Not applicable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal L24 domain containing 1 pseudogene 11 (RSL24D1P11).